Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Molybdenum disulfide | MoS2 | 1317-33-5 | Details |
| 2,4-D Butyl ester；Lironox 326;NSC 409767;2,4-D-butyl | C12H14Cl2O3 | 94-80-4 | Details |
| HHQ | C16H21NO | 40522-46-1 | Details |
| KT5926；KT 5926;KT-5926 | C30H27N3O6 | 126643-38-7 | Details |
| 1-(1-Naphthyl) piperazine hydrochloride | C14H17ClN2 | 104113-71-5 | Details |
| Vandetanib Fumarate；Zactima;Vandetanib;HSDB 8198;ZD 6474;Caprelsa | C22H24BrFN4O2 | 338992-00-0 | Details |
| Lysyllysyllysine；L-Lysine, L-lysyl-L-lysyl-;Lys-lys-lys;Trilysine | C18H38N6O4 | 13184-14-0 | Details |
| CI-988 | C35H42N4O6 | 130332-27-3 | Details |
| Nilofabicin | C19H20N2O2S | 934628-27-0 | Details |
| Rilpivirine HCl；TMC 278. trade name Edurant;Rilpivirine hydrochloride;TMC278;TMC-278;Rilpivirine | C22H19ClN6 | 700361-47-3 | Details |
| MGS0028；MGS 0028;MGS-0028 | C8H8FNO5 | 321963-33-1 | Details |
| SB399885 | C18H21Cl2N3O4S | 402713-80-8 | Details |
| T 98475 | C37H37F2N3O4S | 199119-18-1 | Details |
| CP 154526 | C23H33ClN4 | 257639-98-8 | Details |
| LRGILS-NH2 | C29H56N10O7 | 245329-01-5 | Details |
| AZD-5597；(S)-(4-((5-Fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrimidin-2-yl)amino)phenyl)(3-(methylamino)pyrrolidin-1-yl)methanone | C23H28FN7O | 924641-59-8 | Details |
| Maleic hydrazide；Antergon;Hydrazide maleique;Burtolin;Antyrost | C4H4N2O2 | 123-33-1 | Details |
| Glemanserin | C20H25NO | 107703-78-6 | Details |
| Lenacil | C13H18N2O2 | 2164-08-1 | Details |
| DL-AP5 Sodium salt | C5H11NNaO5P | 1303993-72-7 | Details |
| Methoxyfenozide | C22H28N2O3 | 161050-58-4 | Details |
| Aletamine hydrochloride | C11H16ClN | 4255-24-7 | Details |
| Strontium chloride | Cl2Sr | 10476-85-4 | Details |
| EGFR/ErbB-2/ErbB-4 inhibitor-2 | C23H21N3O3 | 179248-61-4 | Details |
| Tigecycline hydrochloride | C29H40ClN5O8 | 197654-04-9 | Details |
| BD 1008 dihydrobromide | C15H22Cl2N2 | 138356-09-9 | Details |
| SPK-601；LMV-601 | C11H17KOS2 | 1096687-52-3 | Details |
| (R)-Viloxazine Hydrochloride | C13H20ClNO3 | 56287-63-9 | Details |
| RDEA-806 free acid；VRX 806;RDEA-806;AR-806;RDEA 806;AR 806;VRX-806 | C24H18BrClN4O3S | 878670-61-2 | Details |
| AT-9283 L-lactate；AT-9283;AT9283;AT 9283 | C22H29N7O5 | 896466-76-5 | Details |
| Org-29647 | C26H28ClN3O5 | 868273-12-5 | Details |
| SB269652 | C27H30N4O | 215802-15-6 | Details |
| (Z)-FeCP-oxindole | C19H6FeNO | 1137967-28-2 | Details |
| GSK9027 | C27H19F4N3O2S | 1229096-88-1 | Details |
| PD-161570；PD 161570 | C26H35Cl2N7O | 192705-80-9 | Details |
| S 25585 | C22H23F3N4O6S | 263849-50-9 | Details |
| BPIPP | C22H16BrN3O3 | 325746-94-9 | Details |
| SGS518 oxalate；SGS 518 oxalate | C23H24F2N2O7S | 445441-27-0 | Details |
| WAY 267464 dihydrochloride | C32H35N7O4 | 847375-16-0 | Details |
| Flt3 Inhibitor IV；Flt3 Inhibitor-IV;Flt3-IN-IV | C13H12N4 | 819058-89-4 | Details |
| Neramexane Mesylate；KRP-209;KRP209;KRP 209 | C11H23N.CH4O3S | 457068-92-7 | Details |
| (±)-BI-D | C25H27NO4 | 1416258-16-6 | Details |
| GPi 688 | C19H18ClN3O4S | 918902-32-6 | Details |
| IEM 1925 dihydrobromide | C17H28N2.2HBr | 258282-23-4 | Details |
| AM-2232；AM2232;AM 2232;UNII-40KCH8YIKP | C24H20N2O | 335161-19-8 | Details |
| Ciluprevir；BILN 2061;BILN2061ZW;BILN 2061ZW;BILN-2061;BILN2061;BILN-2061ZW | C40H50N6O8S | 300832-84-2 | Details |
| trans-Ned 19 | C30H31FN4O3 | 1354235-96-3 | Details |
| m-PEG12-NHS ester | C30H55NO16 | 756525-94-7 | Details |
| SCH-1473759 | C20H26N8OS | 1094069-99-4 | Details |
| YM928；YM 928;YM-928 | C14H10ClN3OS | 190842-36-5 | Details |
| ARRY-380 (analog ) | C29H27N7O4S | 937265-83-3 | Details |
| 3-Hydroxy-3'-nitro-2-naphthanilide | C17H12N2O4 | 135-65-9 | Details |
| Azelastine | C22H24ClN3O | 58581-89-8 | Details |
| RWJ 52353 | C11H10N2S | 245744-10-9 | Details |
| Balapiravir hydrochloride；RO4588161;R-1626;R 1626;RO-4588161;Balapiravir HCl;R1626;RO 4588161 | C21H31ClN6O8 | 690270-65-6 | Details |
| GSK 189254 HCl；GSK-189254A;GSK 189254 hydrochloride;GSK 189254A;GSK189254A | C21H26ClN3O2 | 945493-87-8 | Details |
| FKGK11 | C13H13F5O | 1071000-98-0 | Details |
| Tetrahydrofolic acid | C19H23N7O6 | 135-16-0 | Details |
| JWH-022；JWH022;JWH 022 | C24H21NO | 209414-16-4 | Details |
| SPD304 | C32H32F3N3O2 | 869998-49-2 | Details |
| GSK2334470 | C25H34N8O | 1227911-45-6 | Details |
| CFMB | C21H21ClN2OS | 1208552-99-1 | Details |
| Anavenol | C12H12O2 | 93-20-9 | Details |
| JNJ-42314415；JNJ 42314415;JNJ42314415 | C19H23N5O2 | 1334165-90-0 | Details |
| BMS-986094；INX08189;INX189;INX 08189;BMS986094;INX-08189;INX-189 | C30H39N6O9P | 1234490-83-5 | Details |
| Diprotin A | C17H31N3O4 | 90614-48-5 | Details |
| Butacaine | C18H30N2O2 | 149-16-6 | Details |
| JNJ-28312141；JNJ 28312141;JNJ28312141 | C26H32N6O2 | 885692-52-4 | Details |
| Ro 32-0432 hydrochloride | C28H28N4O2 | 151342-35-7 | Details |
| Sotrastaurin acetate | C27H26N6O4 | 908351-31-5 | Details |
| Vidupiprant；AMG 853 | C28H27Cl2FN2O6S | 1169483-24-2 | Details |
| BAM7 | C21H19N5O2S | 331244-89-4 | Details |
| SB 611812 | C17H16Cl3F3N2O3S | 345892-71-9 | Details |
| LIMK-IN-14；LIMKIN14;LIMK inhibitor 14;LIMK IN 14;LIMK inhibitor-14 | C22H27N7O3 | 1116570-97-8 | Details |
| Cazpaullone | C16H10N4O | 914088-64-5 | Details |
| GSK-982；GSK 982;GSK982 | C22H27N3O | 934763-10-7 | Details |
| TC-E 5005 | C15H18N4O | 959705-64-7 | Details |
| JNJ-26990990 | C9H10N2O2S2 | 877316-38-6 | Details |
| Ecraprost；Circulase;AS013;Lipo-pro-prostaglandin E1;AS 013;AS-013 | C28H48O6 | 136892-64-3 | Details |
| Takeda-6d | C27H19ClFN5O3S | 1125632-93-0 | Details |
| Mecrylate | C5H5NO2 | 137-05-3 | Details |
| AGK7 | C23H13Cl2N3O2 | 304896-21-7 | Details |
| Org-25935；Org 25935;SCH 900435;SCH-900435 | C21H26ClNO3 | 949588-40-3 | Details |
| GSK 224876；GSK224876;GSK-224876 | 1097733-15-7 | Details |
| Tyrosyltyrosine；Peptide tyrosine-tyrosine;Tyr-tyr;Tyrosyl tyrosine | C18H20N2O5 | 1050-28-8 | Details |
| AG-1859；AG 1859;AG001859;AG-001859;AG 001859;AG1859 | C27H33N3O5S | 478410-84-3 | Details |
| Zanamivir hydrate；J1.917.534K;D01937 | C12H22N4O8 | 551942-41-7 | Details |
| SAD-448；SAD 448;SAD448 | C24H28N4O8S | 581106-09-4 | Details |
| HLI98C；HLI 98C;HLI-98C | C17H9ClN4O4 | 317326-90-2 | Details |
| AS1938909；AS-1938909;AS 1938909 | C19H13Cl2F2NO2S | 1243155-40-9 | Details |
| CRS-3123；REP 3123;CRS3123;REP-3123;CRS 3123 | C19H19Br2N3O2S | 1013915-71-3 | Details |
| AM-8553；AM 8553;AM8553 | C25H29Cl2NO4 | 1352064-70-0 | Details |
| CFLZ-171 TFA salt | C9H17NO2.C2HF3O2 | 247068-85-5 | Details |
| TC-S 7009 | C12H6ClFN4O3 | 1422955-31-4 | Details |
| EC 144 | C21H24ClN5O2 | 911397-80-3 | Details |
| Acarbose sulfate | C25H45NO22S | 1221158-13-9 | Details |
| KCC009；KCC 009;KCC-009 | C21H22BrN3O5 | 744198-19-4 | Details |
| Alvameline Tartrate；LU-25-109T;LU-25109T;LU 25109T;LU 25 109T | C13H21N5O6 | 159792-14-0 | Details |
| Pimobendan hydrochloride | C19H19ClN4O2 | 77469-98-8 | Details |
| Physostigmine hemisulfate | C30H44N6O8S | 64-47-1 | Details |
| Product Total： Product Page： | ||||
| 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 | ||||